MarketBeat on MSN1h
Merck: 4 No-Brainer Reasons to Buy This DipBig pharma has come under a lot of scrutiny from regulators and consumers as sentiment sours on the industry. As such, the ...
SpringWorks Therapeutics ( NASDAQ: SWTX) soared 12% after a report that Merck KGaA ( OTCPK:MKGAF) is in advanced discussions to acquire the cancer and rare disease drugmaker.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback